The Daily Overview on MSN
Eli Lilly closes in on a deal to buy biotech Ventyx
Eli Lilly is moving to deepen its bet on inflammatory disease, striking a deal to acquire biotech player Ventyx Biosciences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback